{"filing":{"accession_number":"0001193125-26-321176","cik":"0001544227","ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-27","primary_document":"d105624d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526321176/d105624d8k.htm"},"events":[{"id":21189,"run_id":19099,"accession_number":"0001193125-26-321176","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Tempest Therapeutics held a special stockholder meeting on July 27, 2026 to vote on a Certificate of Amendment proposal to modify voting requirements and permit written consent. The proposal failed to achieve the required 75% supermajority vote, and the meeting was adjourned to August 17, 2026 to allow additional voting time.","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20756,"accession_number":"0001193125-26-321176","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Item 5.07 is the dedicated disclosure item for shareholder vote results at annual or special meetings. The filing references incorporation of Item 8.01 content, which typically contains the substantive details of the matters voted upon and their outcomes. Shareholder votes on governance, compensation, or other material matters are material to investors' assessment of corporate governance and control.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:51:47.656736+00:00","company_name":"","ticker":null,"filing_date":""},{"id":20757,"accession_number":"0001193125-26-321176","item_number":"8.01","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses the results and adjournment of a special stockholder meeting held on July 27, 2026, where a Certificate of Amendment proposal to modify voting requirements and permit written consent failed to achieve the required 75% supermajority vote. The meeting was adjourned to August 17, 2026 to allow additional voting time. This is a material governance event affecting stockholder voting rights and corporate control mechanisms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:51:47.656736+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20756,"accession_number":"0001193125-26-321176","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Item 5.07 is the dedicated disclosure item for shareholder vote results at annual or special meetings. The filing references incorporation of Item 8.01 content, which typically contains the substantive details of the matters voted upon and their outcomes. Shareholder votes on governance, compensation, or other material matters are material to investors' assessment of corporate governance and control.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:51:47.656736+00:00","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-07-28"},{"id":20757,"accession_number":"0001193125-26-321176","item_number":"8.01","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses the results and adjournment of a special stockholder meeting held on July 27, 2026, where a Certificate of Amendment proposal to modify voting requirements and permit written consent failed to achieve the required 75% supermajority vote. The meeting was adjourned to August 17, 2026 to allow additional voting time. This is a material governance event affecting stockholder voting rights and corporate control mechanisms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:51:47.656736+00:00","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-07-28"}]}